Elazer R. Edelman, an engineer and cardiologist known for developing cardiovascular stents used by over 100 million people, has been awarded the 2026-2027 James R. Killian Jr. Faculty Achievement Award. The award committee recognized Edelman, the Edward J. Poitras Professor in Medical Engineering at MIT’s Institute for Medical Engineering and Science, for his contributions at the intersection of engineering, science, and medicine. Besides his stent work, he has significantly contributed to tissue engineering and understanding the biological processes underlying cardiovascular disease. With more than 30 years on the MIT faculty, Edelman is renowned as a teacher and mentor, also serving as a professor of medicine at Harvard Medical School and a critical care cardiologist at Brigham and Women’s Hospital. He directed MIT’s Institute for Medical Engineering and Science from 2018 to 2024. The award citation was presented at today’s faculty meeting by Xuanhe Zhao, chair of the Killian Award Selection Committee. Established in 1971, the Killian Award honors outstanding professional contributions by MIT faculty, representing the highest honor the faculty can bestow upon a member. Edelman commented, “It’s deeply meaningful that your colleagues think enough of you to want to recognize your life’s work.”
Growing up in Brookline, Massachusetts, Edelman first experienced MIT as a high school student in the Institute’s High School Studies Program, which led him to apply to MIT. He earned two bachelor’s degrees in applied biology and electrical engineering and computer science, followed by a master’s in bioelectrical engineering and a PhD in medical engineering and medical physics, also obtaining an MD from Harvard Medical School through the Harvard-MIT Program in Health Sciences and Technology. As a graduate student, he joined Robert Langer's lab, developing mathematical approaches for controlled drug-delivery systems. Early in his career, Edelman focused on addressing diseased blood vessels without causing further injury. His studies of the cellular and molecular mechanisms of atherosclerosis and vascular healing, combined with insights from engineering and physics, facilitated the optimization of bare-metal stents and the development of drug-eluting stents. Approximately 90% of the over 100 million stents implanted worldwide now utilize drug release principles defined by his research, saving countless lives and improving patients' quality of life.
Edelman’s work illustrates a continuous cycle of discovery: fundamental insights in biology drive transformative medical technologies, while the challenges posed by these technologies push biology, science, technology, and engineering toward new discoveries and clinical advancements. The award committee noted, “His landmark work on the cellular mechanisms underlying atherosclerosis and on the biology of cell-material interfaces established the scientific foundations that transformed bare-metal cardiovascular stents from a promising mechanical concept into a biologically informed and clinically transformative therapy with an enduring legacy.”
More recently, Edelman’s lab has designed novel heart valves and other innovative approaches to mechanical organ support. During his tenure as director of IMES, he led efforts to provide personal protective equipment to healthcare workers and emergency responders early in the Covid-19 pandemic. “One of the things I’m most proud of is working with many people at MIT in the Covid response. At the height of Covid, we were supplying 23 percent of all PPE throughout New England,” he stated. “Every single person who could possibly contribute contributed.” As director of MIT’s Center for Clinical Translational Research and faculty lead for the Hood Pediatric Innovation Hub, he is now working to help clinical research thrive at MIT and address inequities in technology access for society’s most vulnerable population—children.
Throughout his career, Edelman has dedicated himself to mentoring students and trainees. “I’m really proud of what our students have accomplished, not only scientifically, but on a personal level, and not only with me, but everything they’ve done afterwards. The greatness of a place like MIT is that you enable people to grow beyond their potential,” he remarked. In recognition of his scientific achievements, Edelman has been elected a fellow of several distinguished organizations, including the American College of Cardiology, the American Heart Association, the Association of University Cardiologists, the American Society of Clinical Investigation, the American Institute of Medical and Biological Engineering, the American Academy of Arts and Sciences, the National Academy of Inventors, the Institute of Medicine/National Academy of Medicine, and the National Academy of Engineering. The selection committee concluded, “The Selection Committee is delighted to have this opportunity to honor Professor Elazer Edelman for his exceptional contributions to medical engineering and science, to MIT, and to the world.”
Blogger's Review: Professor Elazer Edelman's achievements exemplify the integration of technology and humanitarian efforts, propelling advancements in medical technology. His career serves as a model for how scientists can impact society, inspiring more young individuals to engage in the intersection of technology and medicine. Undoubtedly, his work will continue to influence the future of medical development.